MediciNova, Inc. (MNOV)
1.52
-0.02
(-1.30%)
USD |
NASDAQ |
Oct 09, 16:00
1.53
+0.01
(+0.66%)
After-Hours: 20:00
MediciNova Free Cash Flow : -9.124M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.124M |
| March 31, 2026 | -9.510M |
| December 31, 2025 | -9.813M |
| September 30, 2025 | -9.728M |
| June 30, 2025 | -10.05M |
| March 31, 2025 | -10.56M |
| December 31, 2024 | -10.64M |
| September 30, 2024 | -9.211M |
| June 30, 2024 | -8.553M |
| March 31, 2024 | -8.143M |
| December 31, 2023 | -7.452M |
| September 30, 2023 | -10.97M |
| June 30, 2023 | -12.31M |
| March 31, 2023 | -12.37M |
| December 31, 2022 | -12.92M |
| September 30, 2022 | -12.54M |
| June 30, 2022 | -12.84M |
| March 31, 2022 | -9.285M |
| December 31, 2021 | -9.410M |
| September 30, 2021 | -7.753M |
| June 30, 2021 | -8.644M |
| March 31, 2021 | -11.84M |
| December 31, 2020 | -10.86M |
| September 30, 2020 | -11.29M |
| June 30, 2020 | -9.422M |
| Date | Value |
|---|---|
| March 31, 2020 | -8.986M |
| December 31, 2019 | -9.136M |
| September 30, 2019 | -8.368M |
| June 30, 2019 | -8.065M |
| March 31, 2019 | -8.066M |
| December 31, 2018 | -9.124M |
| September 30, 2018 | -8.526M |
| June 30, 2018 | -8.710M |
| March 31, 2018 | -8.467M |
| December 31, 2017 | -6.924M |
| September 30, 2017 | -6.954M |
| June 30, 2017 | -6.651M |
| March 31, 2017 | -6.737M |
| December 31, 2016 | -6.631M |
| September 30, 2016 | -7.071M |
| June 30, 2016 | -6.627M |
| March 31, 2016 | -6.362M |
| December 31, 2015 | -7.155M |
| September 30, 2015 | -6.671M |
| June 30, 2015 | -7.090M |
| March 31, 2015 | -7.185M |
| December 31, 2014 | 0.813M |
| September 30, 2014 | -2.188M |
| June 30, 2014 | -2.488M |
| March 31, 2014 | -3.301M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ironwood Pharmaceuticals, Inc. | 185.55M |
| Viking Therapeutics, Inc. | -418.44M |
| IDEAYA Biosciences, Inc. | -113.87M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.92M |
| Free Cash Flow Per Share (Quarterly) | -0.039 |
| Free Cash Flow to Equity (Quarterly) | -1.872M |
| Free Cash Flow to Firm (Quarterly) | -1.92M |
| Free Cash Flow Yield | -12.21% |